NQO1 - NAD(P)H quinone dehydrogenase 1 Gene
Also Known as DTD; QR1; DHQU; DIA4; NMOR1; NMORI
Species: Homo sapiens
About NQO1
This gene has 7 transcripts (splice variants), 195 orthologues, 1 paralogue and is associated with 1 phenotype. Biased expression in stomach (RPKM 136.7), gall bladder (RPKM 67.3) and 11 other tissues.
Summary
This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces Quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of Quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of Cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
NQO1 Products (4)
| mRNA | Protein | Name |
|---|---|---|
| NM_000903.3 | NP_000894.1 | NAD(P)H dehydrogenase [quinone] 1 isoform a |
| NM_001025433.2 | NP_001020604.1 | NAD(P)H dehydrogenase [quinone] 1 isoform b |
| NM_001025434.2 | NP_001020605.1 | NAD(P)H dehydrogenase [quinone] 1 isoform c |
| NM_001286137.2 | NP_001273066.1 | NAD(P)H dehydrogenase [quinone] 1 isoform d |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables NADH:ubiquinone reductase (non-electrogenic) activity |
IDA
IDA: Inferred from direct assay
|
8999809 | GOA |
| enables identical protein binding |
IPI
IPI: Inferred from physical interaction
|
25143260 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
15687255 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in cell redox homeostasis |
IEP
IEP: Inferred from expression pattern
|
21636573 | GOA |
| involved in cellular response to oxidative stress |
IDA
IDA: Inferred from direct assay
|
15687255 | GOA |
| involved in negative regulation of ferroptosis |
IMP
IMP: Inferred from mutant phenotype
|
26403645 | GOA |
| involved in negative regulation of protein catabolic process |
IDA
IDA: Inferred from direct assay
|
15687255 | GOA |
| involved in removal of superoxide radicals |
IDA
IDA: Inferred from direct assay
|
15102952 | GOA |
| involved in response to oxidative stress |
IEP
IEP: Inferred from expression pattern
|
21636573 | GOA |
| involved in ubiquinone metabolic process |
IDA
IDA: Inferred from direct assay
|
9271353 | GOA |
| involved in vitamin E metabolic process |
IDA
IDA: Inferred from direct assay
|
9271353 | GOA |
| involved in vitamin K metabolic process |
IDA
IDA: Inferred from direct assay
|
8999809 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in cytosol |
IDA
IDA: Inferred from direct assay
|
10945627 | GOA |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
NAD(P)H dehydrogenase [quinone] 1 |
|
NQO1 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
NQO1 | P15559 | ING1 | Homo sapiens | Q9UK53 | 18388957 | |
|
Intra
|
NQO1 | P15559 | NQO1 | Homo sapiens | P15559 | 25143260 | |
|
Intra
|
NQO1 | P15559 | NQO1 | Homo sapiens | P15559 | 25143260 | |
|
Intra
|
NQO1 | P15559 | NQO1 | Homo sapiens | P15559 | 25143260 |
Recombinant NQO1 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P74405 | Azoreductase/NQO1 Protein, Human (His) | P15559-1 (M1-K274) | ≥ 90%, as determined by reducing SDS-PAGE. |
| HY-P74405A | Azoreductase/NQO1 Protein, Human | P15559-1 (M1-K274) | ≥ 95%, as determined by reducing SDS-PAGE. |
NQO1 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P80250 | NQO1 Antibody (YA697) | WB | Human, Rat |
| HY-P80251 | NQO1 Antibody (YA261) | WB, ICC/IF, IP, FC | Human, Mouse |
| HY-P84116 | NQO1 Antibody (YA3813) | WB, ICC/IF, FC, ELISA | Human, Rat, Monkey |
| HY-P84116A | NQO1 Antibody (YA3813)(PBS only) | WB, ICC/IF, FC, ELISA | Human, Rat, Monkey |
| HY-P86526 | NQO1 Antibody (YA6218) | WB, IHC-P, ICC/IF, IP, ELISA | Human, Mouse, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Tardive Dyskinesia |
|
|
| Colon Adenocarcinoma |
|
|
| Adenocarcinoma |
|
|
| Alcoholic Pancreatitis |
|
|
| Hepatocellular Adenoma |
|
|
| Aplastic Anemia |
|
|
| Colorectal Cancer |
|
|
| Lung Cancer |
|
|
| Bladder Cancer |
|
|
| Acetaminophen Metabolism |
|
|
| Barrett Esophagus |
|
|
| Lung Benign Neoplasm |
|
|
| Childhood Acute Lymphocytic Leukemia |
|
|
| Pancreatic Cancer |
|
|
| Myelodysplastic Syndrome |
|
|
| Ovarian Cancer |
|
|
| Brain Cancer |
|
|
| Asthma |
|
|
| Breast Cancer |
|
|
| Methemoglobinemia |
|
|
| Nijmegen Breakage Syndrome |
|
|
| Gastric Cancer |
|
|
| Hepatocellular Carcinoma |
|
|
| Prostate Cancer |
|
|
| Osebold-Remondini Syndrome |
|
|
| Lung Cancer Susceptibility 3 |
|
|
| Parkinson Disease, Late-Onset |
|
|
| Leukemia, Acute Lymphoblastic |
|
|
| Developmental And Epileptic Encephalopathy 75 |
|
|
| Renal Pelvis Transitional Cell Carcinoma |
|
|
| Schizophrenia |
|
|
| Diabetes Mellitus |
|
|
| Lymphoma, Non-Hodgkin, Familial |
|
|
| Alzheimer Disease, Familial, 1 |
|
|
| Nervous System Disease |
|
|
| Amyotrophic Lateral Sclerosis 1 |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Mus musculus | NQO1 | MGD | MGI:103187 |
| Bos taurus | NQO1 | VGNC | VGNC:57053 |
| Macaca mulatta | NQO1 | VGNC | VGNC:99530 |
| Rattus norvegicus | NQO1 | RGD | RGD:2503 |
| Canis familiaris | NQO1 | VGNC | VGNC:53429 |
| Others | NQO1 | NCBI |